Answer created by AI
- Like
- Disike
AI result is experimental
Generating Answer...
-
Clinical Trials (9730)
-
Therapy Area (2572)
-
Technology (2480)
-
The next chapter of clinical trial services (2336)
-
Suvoda WP (2263)
-
Covid-19 (1663)
-
Approvals (1659)
-
Oncology (1546)
-
Drug Development (1402)
-
Infectious Disease (1393)
-
Genomics (1205)
-
API Manufacturers (1131)
-
Foreign Direct Investment (1119)
-
Clinical Trials Arena (794)
-
COVID Cross-sector Impact Brief (530)
-
Country Risk Report Q4 2021 - Professional Services (506)
-
Oracle NAS WP (464)
-
Central Nervous System (419)
-
Neurology (370)
No Filter Selected
-
News Analysis and Comments (17395)
-
Projects (744)
-
Press Releases (651)
-
White Papers (554)
-
Suppliers (280)
-
Supplier Products (105)
No Filter Selected
-
Clinical Trials (59)
-
Contract Research Organization (53)
-
Artificial Intelligence (14)
-
Clinical Data Management Services (13)
-
Consulting (13)
-
Cloud (12)
-
Clinical Pharmacological Services (11)
-
Clinical Trial Patient Recruitment (11)
-
Cybersecurity (11)
-
Internet of Things (11)
-
Analytical Services (10)
-
Bioavailability Studies (10)
-
Biomarker Services (10)
-
Clinical Development Services (10)
-
Clinical Trial Design Services (10)
-
Clinical Trial Monitoring (10)
-
Clinical Trial Site Selection and Management (10)
-
Contract Manufacturers (10)
-
Environmental, Social, and Governance (10)
-
Software & Technology (10)
No Filter Selected
-
United States (4822)
-
Global (1092)
-
United Kingdom (696)
-
North America (695)
-
Europe (562)
-
China (442)
-
United States of America (247)
-
Australia (229)
-
Asia-Pacific (213)
-
Switzerland (189)
-
France (183)
-
Canada (182)
-
UK (181)
-
Japan (167)
-
Germany (141)
-
India (120)
-
Israel (104)
-
US (103)
-
Russia (91)
-
South Korea (71)
No Filter Selected
-
Artificial Intelligence (7)
-
Big Data (5)
-
Biosimilars (1)
-
Blockchain (2)
-
Cell & Gene Therapy (1)
-
Cloud (4)
-
Corporate Governance (4)
-
Covid-19 (4)
-
Cybersecurity (5)
-
Digitalization (2)
-
Easy & Affordable (1)
-
Electronic Medical Record (EMR) Systems (1)
-
Environmental Sustainability (5)
-
Future of Work (3)
-
Genomics (1)
-
Health & Wellness (1)
-
Immuno-oncology (7)
-
Internet of Things (3)
-
Microbiome (2)
-
Mobile Health (1)
No Filter Selected
Breyanzi (lisocabtagene maraleucel) for the Treatment of Large B-cell Lymphoma (LBCL), USA
Breyanzi is a CD19-directed chimeric antigen receptor (CAR) T-cell immunotherapy indicated for the treatment of adult patients with relapsed or…
Zinforo (ceftaroline fosamil) for the Treatment of Complicated Skin and Soft Tissue Infections
Zinforo (ceftaroline fosamil) is a new intravenous cephalosporin antibiotic indicated for the treatment of serious skin infections or community-acquired pneumonia.…
RYBREVANT (amivantamab-vmjw) for the Treatment of Non-Small Cell Lung Cancer
Rybrevant (amivantamab-vmjw) is the first fully-human bispecific antibody indicated for the treatment of adult patients with metastatic non-small cell lung…
Imbruvica (Ibrutinib) for the Treatment of Mantle Cell Lymphoma (MCL)
Imbruvica (ibrutinib) is an oral Bruton’s tyrosine kinase (BTK) inhibitor indicated for the treatment of mantle cell lymphoma (MCL) patients…
Kalbitor - Treatment for Hereditary Angioedema
Kalbitor (ecallantide) is a drug developed by US-based Dyax Corp for the treatment of hereditary angioedema (HAE). The drug was…
Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington’s Disease
Austedo™ (deutetrabenazine) is a vesicular monoamine transporter 2 (VMAT 2) inhibitor indicated for the treatment of chorea associated with Huntington’s…
VOXZOGO (vosoritide) for the Treatment of Achondroplasia and Open Epiphyses, USA
VOXZOGO™ (vosoritide) is a once-daily therapeutic medicine indicated for the treatment of achondroplasia in children aged five years and older…
Alofisel (darvadstrocel) for the Treatment of Complex Perianal Fistulas in Crohn’s Disease
Alofisel® (formerly Cx601 / darvadstrocel) is the first allogeneic stem cell therapy to be approved for the treatment of complex…
Ceftazidime-Avibactam for Treatment of Complicated Urinary Tract and Intra-Abdominal Infections
Ceftazidime-avibactam is an investigational antibiotic indicated for treatment of patients with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections…
Zerbaxa (ceftolozane/tazobactam) for the Treatment of Gram-negative Bacterial Infections
Zerbaxa (ceftolozane/tazobactam) is an antibiotic developed and marketed by Merck (formerly Cubist Pharmaceuticals (Cubist)), for the treatment of infections caused…
Shingrix (herpes zoster subunit vaccine) for the Prevention of Shingles
Shingrix is a recombinant subunit shingles vaccine that was discovered and developed by GlaxoSmithKline (GSK). GSK submitted the vaccine for…
Ibrance (palbociclib) for the Treatment of Metastatic Breast Cancer
Ibrance (palbociclib) is an oral formulation developed by Pfizer for the treatment of metastatic breast cancer in women with disease…
Galida - Dual PPAR
AstraZeneca’s, Galida (tesaglitazar) is a dual-acting oral Peroxisome Proliferator-Activated Receptor (PPAR) agonist that was under development for the treatment of…
Strensiq (asfotase alfa) for the Treatment of Hypophosphatasia
Strensiq (asfotase alfa) is the first enzyme replacement therapy (ERT) approved in the US for the treatment of perinatal /…
Arexvy (RSV vaccine) to Prevent Lower Respiratory Tract Disease (LRTD), USA
Arexvy is a first-of-its-kind adjuvanted respiratory syncytial virus (RSV) vaccine indicated as a preventive measure against lower respiratory tract disease…
Uceris (Budesonide) for Treating Ulcerative Colitis
Uceris (budesonide) is glucocorticoid receptor that is indicated for the treatment of ulcerative colitis. It is developed by US-based biopharmaceutical…
Promacta (eltrombopag) for the Treatment of Severe Aplastic Anaemia (SAA)
Promacta (eltrombopag) is the first-in-class treatment indicated for patients with severe aplastic anaemia (SAA) immunosuppressive therapy (IST) was proven ineffective…
Contrave for the Treatment of Obesity
Contrave (Bupropion / naltrexone) is a drug indicated for treating obesity. The drug was developed by Orexigen Therapeutics. Orexigen submitted…
Gamifant (emapalumab-lzsg) for Primary Haemophagocytic Lymphohistiocytosis
Gamifant® (emapalumab-lzsg) is an interferon-gamma (IFNγ) blocking antibody indicated for the treatment of primary haemophagocytic lymphohistiocytosis (HLH) in paediatric and…
Zynteglo for the Treatment of Transfusion-Dependent Beta-thalassemia
Zynteglo™ is a gene therapy indicated for the treatment of transfusion-dependent beta (β)-thalassemia (TDT) in patients aged 12 years and…
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- 255
- 256
- 257
- 258
- 259
- 260
- 261
- 262
- 263
- 264
- 265
- 266
- 267
- 268
- 269
- 270
- 271
- 272
- 273
- 274
- 275
- 276
- 277
- 278
- 279
- 280
- 281
- 282
- 283
- 284
- 285
- 286
- 287
- 288
- 289
- 290
- 291
- 292
- 293
- 294
- 295
- 296
- 297
- 298
- 299
- 300
- 301
- 302
- 303
- 304
- 305
- 306
- 307
- 308
- 309
- 310
- 311
- 312
- 313
- 314
- 315
- 316
- 317
- 318
- 319
- 320
- 321
- 322
- 323
- 324
- 325
- 326
- 327
- 328
- 329
- 330
- 331
- 332
- 333
- 334
- 335
- 336
- 337
- 338
- 339
- 340
- 341
- 342
- 343
- 344
- 345
- 346
- 347
- 348
- 349
- 350
- 351
- 352
- 353
- 354
- 355
- 356
- 357
- 358
- 359
- 360
- 361
- 362
- 363
- 364
- 365
- 366
- 367
- 368
- 369
- 370
- 371
- 372
- 373
- 374
- 375
- 376
- 377
- 378
- 379
- 380
- 381
- 382
- 383
- 384
- 385
- 386
- 387
- 388
- 389
- 390
- 391
- 392
- 393
- 394
- 395
- 396
- 397
- 398
- 399
- 400
- 401
- 402
- 403
- 404
- 405
- 406
- 407
- 408
- 409
- 410
- 411
- 412
- 413
- 414
- 415
- 416
- 417
- 418
- 419
- 420
- 421
- 422
- 423
- 424
- 425
- 426
- 427
- 428
- 429
- 430
- 431
- 432
- 433
- 434
- 435
- 436
- 437
- 438
- 439
- 440
- 441
- 442
- 443
- 444
- 445
- 446
- 447
- 448
- 449
- 450
- 451
- 452
- 453
- 454
- 455
- 456
- 457
- 458
- 459
- 460
- 461
- 462
- 463
- 464
- 465
- 466
- 467
- 468
- 469
- 470
- 471
- 472
- 473
- 474
- 475
- 476
- 477
- 478
- 479
- 480
- 481
- 482
- 483
- 484
- 485
- 486
- 487
- 488
- 489
- 490
- 491
- 492
- 493
- 494
- 495
- 496
- 497
- 498
- 499
- 500